nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Fluid overload—Carboplatin—ovarian cancer	0.0564	0.0598	CcSEcCtD
Terlipressin—Skin necrosis—Melphalan—ovarian cancer	0.045	0.0477	CcSEcCtD
Terlipressin—Skin necrosis—Vinorelbine—ovarian cancer	0.0393	0.0417	CcSEcCtD
Terlipressin—Skin necrosis—Paclitaxel—ovarian cancer	0.0264	0.028	CcSEcCtD
Terlipressin—Respiratory distress—Melphalan—ovarian cancer	0.0247	0.0262	CcSEcCtD
Terlipressin—Respiratory failure—Topotecan—ovarian cancer	0.0163	0.0173	CcSEcCtD
Terlipressin—Skin necrosis—Epirubicin—ovarian cancer	0.0151	0.016	CcSEcCtD
Terlipressin—Skin exfoliation—Melphalan—ovarian cancer	0.015	0.0159	CcSEcCtD
Terlipressin—Respiratory distress—Paclitaxel—ovarian cancer	0.0145	0.0154	CcSEcCtD
Terlipressin—Respiratory failure—Vinorelbine—ovarian cancer	0.014	0.0148	CcSEcCtD
Terlipressin—Skin necrosis—Doxorubicin—ovarian cancer	0.014	0.0148	CcSEcCtD
Terlipressin—Skin exfoliation—Vinorelbine—ovarian cancer	0.0131	0.0139	CcSEcCtD
Terlipressin—Pulmonary oedema—Vinorelbine—ovarian cancer	0.0122	0.013	CcSEcCtD
Terlipressin—Atrial fibrillation—Melphalan—ovarian cancer	0.012	0.0128	CcSEcCtD
Terlipressin—Vomiting—Altretamine—ovarian cancer	0.0115	0.0122	CcSEcCtD
Terlipressin—Hyponatraemia—Melphalan—ovarian cancer	0.0115	0.0121	CcSEcCtD
Terlipressin—Nausea—Altretamine—ovarian cancer	0.0108	0.0114	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Paclitaxel—ovarian cancer	0.0102	0.0108	CcSEcCtD
Terlipressin—Cardiac failure—Vinorelbine—ovarian cancer	0.0102	0.0108	CcSEcCtD
Terlipressin—Hyponatraemia—Vinorelbine—ovarian cancer	0.01	0.0106	CcSEcCtD
Terlipressin—Respiratory failure—Paclitaxel—ovarian cancer	0.00941	0.00997	CcSEcCtD
Terlipressin—Skin exfoliation—Paclitaxel—ovarian cancer	0.00882	0.00935	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—ovarian cancer	0.00797	0.00845	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.00757	0.00803	CcSEcCtD
Terlipressin—Myocardial infarction—Vinorelbine—ovarian cancer	0.00753	0.00798	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—ovarian cancer	0.00747	0.00792	CcSEcCtD
Terlipressin—Angiopathy—Topotecan—ovarian cancer	0.00731	0.00775	CcSEcCtD
Terlipressin—Hot flush—Paclitaxel—ovarian cancer	0.00717	0.0076	CcSEcCtD
Terlipressin—Menopausal symptoms—Paclitaxel—ovarian cancer	0.00711	0.00753	CcSEcCtD
Terlipressin—Atrial fibrillation—Paclitaxel—ovarian cancer	0.00707	0.0075	CcSEcCtD
Terlipressin—Malnutrition—Topotecan—ovarian cancer	0.00702	0.00744	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—ovarian cancer	0.00697	0.00739	CcSEcCtD
Terlipressin—Cardiac failure—Paclitaxel—ovarian cancer	0.00687	0.00728	CcSEcCtD
Terlipressin—Hyponatraemia—Paclitaxel—ovarian cancer	0.00673	0.00714	CcSEcCtD
Terlipressin—Cardiac disorder—Vinorelbine—ovarian cancer	0.0064	0.00678	CcSEcCtD
Terlipressin—Angiopathy—Vinorelbine—ovarian cancer	0.00626	0.00663	CcSEcCtD
Terlipressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AQP3—ovarian cancer	0.00615	0.108	CbGpPWpGaD
Terlipressin—Hot flush—Docetaxel—ovarian cancer	0.00607	0.00644	CcSEcCtD
Terlipressin—Menopausal symptoms—Docetaxel—ovarian cancer	0.00602	0.00638	CcSEcCtD
Terlipressin—Malnutrition—Vinorelbine—ovarian cancer	0.006	0.00636	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—ovarian cancer	0.006	0.00636	CcSEcCtD
Terlipressin—Chest pain—Topotecan—ovarian cancer	0.00597	0.00633	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00593	0.00629	CcSEcCtD
Terlipressin—Chest pain—Melphalan—ovarian cancer	0.00585	0.0062	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—ovarian cancer	0.00585	0.0062	CcSEcCtD
Terlipressin—Cardiac failure—Docetaxel—ovarian cancer	0.00582	0.00617	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00581	0.00616	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—ovarian cancer	0.00571	0.00605	CcSEcCtD
Terlipressin—Nervous system disorder—Topotecan—ovarian cancer	0.00562	0.00595	CcSEcCtD
Terlipressin—Skin disorder—Topotecan—ovarian cancer	0.00556	0.0059	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00555	0.00589	CcSEcCtD
Terlipressin—Tachycardia—Melphalan—ovarian cancer	0.00547	0.0058	CcSEcCtD
Terlipressin—Skin disorder—Melphalan—ovarian cancer	0.00545	0.00577	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.00541	0.00573	CcSEcCtD
Terlipressin—AVPR2—Aquaporin-mediated transport—AQP3—ovarian cancer	0.00537	0.0946	CbGpPWpGaD
Terlipressin—Hypertension—Vinorelbine—ovarian cancer	0.00518	0.00549	CcSEcCtD
Terlipressin—Chest pain—Vinorelbine—ovarian cancer	0.00511	0.00542	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—ITGA8—ovarian cancer	0.00511	0.09	CbGpPWpGaD
Terlipressin—Dyspnoea—Topotecan—ovarian cancer	0.00511	0.00541	CcSEcCtD
Terlipressin—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00509	0.0054	CcSEcCtD
Terlipressin—Abdominal pain—Chlorambucil—ovarian cancer	0.00509	0.00539	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00508	0.00538	CcSEcCtD
Terlipressin—Myocardial infarction—Paclitaxel—ovarian cancer	0.00506	0.00537	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—ovarian cancer	0.00504	0.00534	CcSEcCtD
Terlipressin—Dyspnoea—Melphalan—ovarian cancer	0.005	0.0053	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00494	0.00524	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00484	0.00513	CcSEcCtD
Terlipressin—Nervous system disorder—Vinorelbine—ovarian cancer	0.0048	0.00509	CcSEcCtD
Terlipressin—Tachycardia—Vinorelbine—ovarian cancer	0.00478	0.00507	CcSEcCtD
Terlipressin—Skin disorder—Vinorelbine—ovarian cancer	0.00476	0.00504	CcSEcCtD
Terlipressin—Bradycardia—Paclitaxel—ovarian cancer	0.00472	0.00501	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—ovarian cancer	0.0047	0.00498	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—ovarian cancer	0.00466	0.00494	CcSEcCtD
Terlipressin—Abdominal pain—Topotecan—ovarian cancer	0.00453	0.0048	CcSEcCtD
Terlipressin—Diarrhoea—Chlorambucil—ovarian cancer	0.0044	0.00467	CcSEcCtD
Terlipressin—Dyspnoea—Vinorelbine—ovarian cancer	0.00437	0.00463	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00435	0.00461	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00432	0.00458	CcSEcCtD
Terlipressin—Cardiac disorder—Paclitaxel—ovarian cancer	0.0043	0.00456	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—ovarian cancer	0.00429	0.00455	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00423	0.00448	CcSEcCtD
Terlipressin—Angiopathy—Paclitaxel—ovarian cancer	0.00421	0.00446	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—ovarian cancer	0.0041	0.00434	CcSEcCtD
Terlipressin—Vomiting—Chlorambucil—ovarian cancer	0.00409	0.00434	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—ovarian cancer	0.00406	0.00431	CcSEcCtD
Terlipressin—Malnutrition—Paclitaxel—ovarian cancer	0.00404	0.00428	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—ovarian cancer	0.00393	0.00416	CcSEcCtD
Terlipressin—Diarrhoea—Topotecan—ovarian cancer	0.00392	0.00415	CcSEcCtD
Terlipressin—Abdominal pain—Vinorelbine—ovarian cancer	0.00387	0.00411	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—ovarian cancer	0.00385	0.00408	CcSEcCtD
Terlipressin—Diarrhoea—Melphalan—ovarian cancer	0.00384	0.00407	CcSEcCtD
Terlipressin—Nausea—Chlorambucil—ovarian cancer	0.00382	0.00405	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—ovarian cancer	0.00379	0.00402	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00376	0.00398	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—ovarian cancer	0.00365	0.00387	CcSEcCtD
Terlipressin—Vomiting—Topotecan—ovarian cancer	0.00364	0.00386	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—ovarian cancer	0.00363	0.00385	CcSEcCtD
Terlipressin—Headache—Topotecan—ovarian cancer	0.00359	0.0038	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—ovarian cancer	0.00357	0.00378	CcSEcCtD
Terlipressin—Vomiting—Melphalan—ovarian cancer	0.00357	0.00378	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—ovarian cancer	0.00356	0.00377	CcSEcCtD
Terlipressin—Hypertension—Paclitaxel—ovarian cancer	0.00349	0.0037	CcSEcCtD
Terlipressin—Chest pain—Paclitaxel—ovarian cancer	0.00344	0.00364	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—ovarian cancer	0.00342	0.00363	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00341	0.00362	CcSEcCtD
Terlipressin—Nausea—Topotecan—ovarian cancer	0.0034	0.00361	CcSEcCtD
Terlipressin—Diarrhoea—Vinorelbine—ovarian cancer	0.00335	0.00355	CcSEcCtD
Terlipressin—Nausea—Melphalan—ovarian cancer	0.00333	0.00353	CcSEcCtD
Terlipressin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00323	0.00343	CcSEcCtD
Terlipressin—Tachycardia—Paclitaxel—ovarian cancer	0.00322	0.00341	CcSEcCtD
Terlipressin—Skin disorder—Paclitaxel—ovarian cancer	0.0032	0.00339	CcSEcCtD
Terlipressin—Vomiting—Vinorelbine—ovarian cancer	0.00311	0.0033	CcSEcCtD
Terlipressin—Headache—Vinorelbine—ovarian cancer	0.00307	0.00325	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—ovarian cancer	0.00295	0.00313	CcSEcCtD
Terlipressin—Dyspnoea—Paclitaxel—ovarian cancer	0.00294	0.00311	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—ovarian cancer	0.00291	0.00309	CcSEcCtD
Terlipressin—Nausea—Vinorelbine—ovarian cancer	0.00291	0.00308	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00289	0.00307	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00284	0.00302	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—ovarian cancer	0.00274	0.0029	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—ovarian cancer	0.00273	0.00289	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—ovarian cancer	0.00271	0.00288	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—ovarian cancer	0.0027	0.00286	CcSEcCtD
Terlipressin—Abdominal pain—Paclitaxel—ovarian cancer	0.0026	0.00276	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—ovarian cancer	0.0025	0.00265	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—ovarian cancer	0.00249	0.00264	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—ovarian cancer	0.00246	0.00261	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00241	0.00256	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—ovarian cancer	0.00241	0.00255	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—ovarian cancer	0.00231	0.00245	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—ovarian cancer	0.00228	0.00241	CcSEcCtD
Terlipressin—Diarrhoea—Paclitaxel—ovarian cancer	0.00225	0.00239	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—ovarian cancer	0.00223	0.00236	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—ovarian cancer	0.00221	0.00234	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—ovarian cancer	0.00214	0.00226	CcSEcCtD
Terlipressin—Vomiting—Paclitaxel—ovarian cancer	0.0021	0.00222	CcSEcCtD
Terlipressin—Headache—Paclitaxel—ovarian cancer	0.00206	0.00219	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—ovarian cancer	0.00199	0.00211	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—ovarian cancer	0.00197	0.00208	CcSEcCtD
Terlipressin—Nausea—Paclitaxel—ovarian cancer	0.00196	0.00207	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00195	0.00207	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—ovarian cancer	0.00191	0.00203	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—ovarian cancer	0.00185	0.00196	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—ovarian cancer	0.00184	0.00195	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—ovarian cancer	0.00184	0.00195	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—ovarian cancer	0.00183	0.00194	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—ovarian cancer	0.00182	0.00193	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00181	0.00191	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—ovarian cancer	0.00178	0.00188	CcSEcCtD
Terlipressin—Headache—Docetaxel—ovarian cancer	0.00175	0.00185	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—ovarian cancer	0.00171	0.00181	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—ovarian cancer	0.0017	0.0018	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—ovarian cancer	0.00169	0.00179	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—ovarian cancer	0.00168	0.00178	CcSEcCtD
Terlipressin—Nausea—Docetaxel—ovarian cancer	0.00166	0.00176	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00163	0.00172	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—ovarian cancer	0.00155	0.00165	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.0015	0.0016	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—ovarian cancer	0.00149	0.00158	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—CDH1—ovarian cancer	0.00147	0.0258	CbGpPWpGaD
Terlipressin—Abdominal pain—Doxorubicin—ovarian cancer	0.00138	0.00146	CcSEcCtD
Terlipressin—Diarrhoea—Epirubicin—ovarian cancer	0.00129	0.00137	CcSEcCtD
Terlipressin—Vomiting—Epirubicin—ovarian cancer	0.0012	0.00127	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—ovarian cancer	0.00119	0.00126	CcSEcCtD
Terlipressin—Headache—Epirubicin—ovarian cancer	0.00118	0.00125	CcSEcCtD
Terlipressin—Nausea—Epirubicin—ovarian cancer	0.00112	0.00119	CcSEcCtD
Terlipressin—Vomiting—Doxorubicin—ovarian cancer	0.00111	0.00117	CcSEcCtD
Terlipressin—Headache—Doxorubicin—ovarian cancer	0.00109	0.00116	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—CTNNB1—ovarian cancer	0.00108	0.0191	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—ovarian cancer	0.00104	0.0011	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—HSD17B6—ovarian cancer	0.00077	0.0136	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000741	0.0131	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.000714	0.0126	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000711	0.0125	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—DLC1—ovarian cancer	0.000655	0.0115	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000562	0.0099	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000558	0.00982	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HSD17B6—ovarian cancer	0.000534	0.0094	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BCL9—ovarian cancer	0.000534	0.0094	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HSD17B6—ovarian cancer	0.00053	0.00934	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.000495	0.00872	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DLC1—ovarian cancer	0.000454	0.008	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DLC1—ovarian cancer	0.00045	0.00794	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—DOK1—ovarian cancer	0.000422	0.00743	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.000405	0.00714	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PPP1CC—ovarian cancer	0.000397	0.00699	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.000388	0.00684	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000386	0.00681	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000384	0.00676	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000375	0.0066	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000374	0.00659	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BCL9—ovarian cancer	0.00037	0.00652	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.000369	0.00651	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.000369	0.0065	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BCL9—ovarian cancer	0.000367	0.00647	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000362	0.00638	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.000358	0.00631	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000349	0.00614	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.00032	0.00564	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HDAC6—ovarian cancer	0.000301	0.0053	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000297	0.00522	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000296	0.00522	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DOK1—ovarian cancer	0.000292	0.00515	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DOK1—ovarian cancer	0.00029	0.00512	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000286	0.00504	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL8—ovarian cancer	0.000285	0.00502	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000284	0.005	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.000281	0.00495	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP1CC—ovarian cancer	0.000275	0.00484	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP1CC—ovarian cancer	0.000273	0.00481	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.000269	0.00474	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—YAP1—ovarian cancer	0.000266	0.00469	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—XIAP—ovarian cancer	0.000261	0.00459	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000259	0.00457	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000257	0.00453	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.000256	0.00451	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.000256	0.00451	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SMARCA4—ovarian cancer	0.000254	0.00447	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.000248	0.00437	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EREG—ovarian cancer	0.000248	0.00437	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000242	0.00426	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PGR—ovarian cancer	0.000232	0.00409	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.000222	0.00391	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000219	0.00385	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PARP1—ovarian cancer	0.000216	0.00381	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HDAC6—ovarian cancer	0.000208	0.00367	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HDAC6—ovarian cancer	0.000207	0.00364	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6ST—ovarian cancer	0.000207	0.00364	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000206	0.00362	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000205	0.00362	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000204	0.0036	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CG—ovarian cancer	0.000198	0.0035	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL8—ovarian cancer	0.000197	0.00348	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000197	0.00346	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL8—ovarian cancer	0.000196	0.00345	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000192	0.00339	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—YAP1—ovarian cancer	0.000184	0.00325	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—YAP1—ovarian cancer	0.000183	0.00323	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—XIAP—ovarian cancer	0.000181	0.00318	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—XIAP—ovarian cancer	0.000179	0.00316	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMARCA4—ovarian cancer	0.000176	0.0031	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PPP2R1A—ovarian cancer	0.000175	0.00309	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMARCA4—ovarian cancer	0.000175	0.00308	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CD—ovarian cancer	0.000174	0.00307	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EREG—ovarian cancer	0.000172	0.00303	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EREG—ovarian cancer	0.000171	0.00301	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000167	0.00295	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PGR—ovarian cancer	0.000161	0.00284	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—ovarian cancer	0.000161	0.00284	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PGR—ovarian cancer	0.00016	0.00282	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—ovarian cancer	0.000154	0.00271	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—ovarian cancer	0.000152	0.00268	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000151	0.00267	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.00015	0.00265	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PARP1—ovarian cancer	0.00015	0.00264	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PARP1—ovarian cancer	0.000149	0.00262	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—ovarian cancer	0.000146	0.00258	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6ST—ovarian cancer	0.000143	0.00252	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6ST—ovarian cancer	0.000142	0.0025	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—ovarian cancer	0.00014	0.00246	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—ovarian cancer	0.000139	0.00245	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—ovarian cancer	0.000138	0.00242	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—ovarian cancer	0.000137	0.00241	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000133	0.00235	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000132	0.00233	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CAV1—ovarian cancer	0.000129	0.00227	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—ovarian cancer	0.000124	0.00219	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6ST—ovarian cancer	0.000122	0.00215	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP2R1A—ovarian cancer	0.000121	0.00214	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—ovarian cancer	0.000121	0.00213	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000121	0.00212	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—ovarian cancer	0.00012	0.00212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—ovarian cancer	0.000117	0.00207	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—ovarian cancer	0.000117	0.00207	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—ovarian cancer	0.000117	0.00207	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000116	0.00205	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000115	0.00203	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—ovarian cancer	0.000112	0.00198	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—ovarian cancer	0.000112	0.00197	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—ovarian cancer	0.000111	0.00195	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK1—ovarian cancer	0.000107	0.00188	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—ovarian cancer	0.000107	0.00188	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—ovarian cancer	0.000107	0.00188	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—ovarian cancer	0.000106	0.00186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—ovarian cancer	0.000105	0.00186	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—ovarian cancer	0.000105	0.00184	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—ovarian cancer	0.000103	0.00182	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000102	0.0018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—ovarian cancer	0.000101	0.00178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—ovarian cancer	0.000101	0.00178	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—ovarian cancer	0.000101	0.00177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—ovarian cancer	9.68e-05	0.00171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—ovarian cancer	9.65e-05	0.0017	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—ovarian cancer	9.61e-05	0.00169	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—ovarian cancer	9.58e-05	0.00169	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—ovarian cancer	9.27e-05	0.00163	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—ovarian cancer	9.1e-05	0.0016	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—ovarian cancer	8.98e-05	0.00158	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—ovarian cancer	8.98e-05	0.00158	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CAV1—ovarian cancer	8.92e-05	0.00157	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CAV1—ovarian cancer	8.86e-05	0.00156	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—ovarian cancer	8.63e-05	0.00152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—ovarian cancer	8.6e-05	0.00151	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—ovarian cancer	8.58e-05	0.00151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—ovarian cancer	8.54e-05	0.0015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6ST—ovarian cancer	8.46e-05	0.00149	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—ovarian cancer	8.43e-05	0.00149	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6ST—ovarian cancer	8.4e-05	0.00148	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—ovarian cancer	8.34e-05	0.00147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—ovarian cancer	8.26e-05	0.00146	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—ovarian cancer	8.25e-05	0.00145	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—ovarian cancer	8.21e-05	0.00145	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—ovarian cancer	8.13e-05	0.00143	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—ovarian cancer	8.13e-05	0.00143	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—ovarian cancer	8.13e-05	0.00143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—ovarian cancer	8.07e-05	0.00142	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—ovarian cancer	8.07e-05	0.00142	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—ovarian cancer	8.07e-05	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—ovarian cancer	8.04e-05	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—ovarian cancer	7.96e-05	0.0014	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—ovarian cancer	7.81e-05	0.00138	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—ovarian cancer	7.78e-05	0.00137	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—ovarian cancer	7.76e-05	0.00137	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—ovarian cancer	7.73e-05	0.00136	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—ovarian cancer	7.57e-05	0.00133	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK1—ovarian cancer	7.41e-05	0.0013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—ovarian cancer	7.4e-05	0.0013	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK1—ovarian cancer	7.35e-05	0.0013	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—ovarian cancer	7.35e-05	0.0013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—ovarian cancer	7.14e-05	0.00126	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—ovarian cancer	7.09e-05	0.00125	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—ovarian cancer	7.08e-05	0.00125	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—ovarian cancer	7.03e-05	0.00124	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—ovarian cancer	7.01e-05	0.00124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—ovarian cancer	6.99e-05	0.00123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—ovarian cancer	6.94e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—ovarian cancer	6.94e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—ovarian cancer	6.93e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—ovarian cancer	6.63e-05	0.00117	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—ovarian cancer	6.45e-05	0.00114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—ovarian cancer	6.43e-05	0.00113	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—ovarian cancer	6.38e-05	0.00112	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK1—ovarian cancer	6.31e-05	0.00111	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—ovarian cancer	6.31e-05	0.00111	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—ovarian cancer	6.31e-05	0.00111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—ovarian cancer	6.26e-05	0.0011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—ovarian cancer	6.23e-05	0.0011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—ovarian cancer	6.23e-05	0.0011	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—ovarian cancer	6.18e-05	0.00109	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—ovarian cancer	6.18e-05	0.00109	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—ovarian cancer	5.98e-05	0.00105	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—ovarian cancer	5.96e-05	0.00105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—ovarian cancer	5.95e-05	0.00105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—ovarian cancer	5.94e-05	0.00105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—ovarian cancer	5.9e-05	0.00104	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—ovarian cancer	5.84e-05	0.00103	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—ovarian cancer	5.8e-05	0.00102	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—ovarian cancer	5.78e-05	0.00102	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—ovarian cancer	5.74e-05	0.00101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—ovarian cancer	5.73e-05	0.00101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—ovarian cancer	5.72e-05	0.00101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—ovarian cancer	5.69e-05	0.001	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—ovarian cancer	5.69e-05	0.001	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—ovarian cancer	5.68e-05	0.001	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—ovarian cancer	5.65e-05	0.000995	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—ovarian cancer	5.57e-05	0.000982	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—ovarian cancer	5.53e-05	0.000975	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—ovarian cancer	5.52e-05	0.000973	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—ovarian cancer	5.48e-05	0.000966	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—ovarian cancer	5.48e-05	0.000965	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—ovarian cancer	5.41e-05	0.000954	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—ovarian cancer	5.38e-05	0.000948	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—ovarian cancer	5.37e-05	0.000947	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—ovarian cancer	5.34e-05	0.000941	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—ovarian cancer	5.3e-05	0.000934	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—ovarian cancer	5.25e-05	0.000925	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—ovarian cancer	5.21e-05	0.000918	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—ovarian cancer	5.07e-05	0.000893	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—ovarian cancer	4.86e-05	0.000856	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—ovarian cancer	4.85e-05	0.000854	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—ovarian cancer	4.83e-05	0.00085	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—ovarian cancer	4.81e-05	0.000848	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—ovarian cancer	4.8e-05	0.000846	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—ovarian cancer	4.78e-05	0.000842	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—ovarian cancer	4.77e-05	0.00084	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—ovarian cancer	4.6e-05	0.00081	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—ovarian cancer	4.56e-05	0.000804	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—ovarian cancer	4.47e-05	0.000788	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—ovarian cancer	4.47e-05	0.000788	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—ovarian cancer	4.44e-05	0.000782	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK1—ovarian cancer	4.37e-05	0.000771	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—ovarian cancer	4.37e-05	0.000771	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK1—ovarian cancer	4.34e-05	0.000765	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—ovarian cancer	4.34e-05	0.000765	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—ovarian cancer	4.13e-05	0.000728	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—ovarian cancer	4.1e-05	0.000723	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—ovarian cancer	3.8e-05	0.000669	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—ovarian cancer	3.77e-05	0.000664	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—ovarian cancer	3.67e-05	0.000647	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—ovarian cancer	3.65e-05	0.000642	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—ovarian cancer	3.51e-05	0.000619	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—ovarian cancer	3.49e-05	0.000614	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—ovarian cancer	3.36e-05	0.000592	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—ovarian cancer	3.34e-05	0.000588	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—ovarian cancer	3.1e-05	0.000546	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—ovarian cancer	3.08e-05	0.000542	CbGpPWpGaD
